Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Recruiting 4Withdrawn 1Unknown 1Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Fasting in Malignant Solid Tumors 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Interventional × Angptl4 protein, mouse × Clear all
NCT00936364 2025-06-02

Short-Term Fasting: Impact on Toxicity

University of Southern California

Phase NA Terminated
47 enrolled
Other solid neoplasm

Fasting in Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡